Pre-operative demographics and clinical characteristics
| Characteristics | Patients (n=261) | % |
| Age group (years) | ||
| <65 | 132 | 50.6 |
| 65–74 | 102 | 39.1 |
| 75–84 | 22 | 8.4 |
| >85 | 5 | 1.9 |
| Functional status | ||
| Independent | 261 | 100.0 |
| Partially dependent | 0 | 0 |
| Totally dependent | 0 | 0 |
| ASA class | ||
| Healthy patient (ASA 1) | 0 | |
| Mild systemic disease (ASA 2) | 169 | 64.8 |
| Severe systemic disease (ASA 3) | 92 | 35.2 |
| Severe systemic disease/constant threat to life (ASA 4) | 0 | |
| Moribund (ASA 5) | 0 | |
| Steroid use for chronic condition | ||
| No | 254 | 97.3 |
| Yes | 7 | 2.7 |
| High (≥4) | 0 | |
| Ascites | ||
| No | 170 | 65.1 |
| Yes | 91 | 34.9 |
| Diabetes | ||
| No | 245 | 93.9 |
| Yes-on oral agent | 10 | 3.8 |
| Yes-on insulin | 6 | 2.3 |
| Hypertension requiring medication | ||
| No | 161 | 61.7 |
| Yes | 100 | 38.3 |
| Congestive heart failure within 30 days prior to surgery | ||
| No | 261 | 100.0 |
| Yes | 0 | 0.0 |
| Dyspnea | ||
| No | 257 | 98.5 |
| With moderate exertion | 4 | 1.5 |
| At rest | 0 | 0.0 |
| Smoker | ||
| No | 190 | 72.8 |
| Yes | 71 | 27.2 |
| History of severe COPD | ||
| No | 259 | 99.2 |
| Yes | 2 | 0.8 |
| Stage | ||
| IIIC | 146 | 55.9 |
| IV | 115 | 44.1 |
| BMI (median, range); n=260 | 25.2 (22.5–28.4) | |
| Histology | ||
| Serous | 242 | 92.7 |
| Mucinous | 1 | 0.4 |
| Endometrioid | 2 | 0.8 |
| Carcinosarcoma | 5 | 1.9 |
| Clear cell | 4 | 1.5 |
| Mixed | 1 | 0.4 |
| Operative time, min (median, range); n=65 | 152 (116–242) | |
| EBL, mL (median, range); n=259 | 300 (150–500) | |
| Surgical complexity | ||
| Low | 154 | 59.0 |
| Moderate | 90 | 34.5 |
| High | 17 | 6.5 |
| Residual disease; n=260 | ||
| Complete surgical resection | 166 | 63.8 |
| Optimal (≤1 cm) | 79 | 30.4 |
| Suboptimal (>1 cm) | 15 | 5.8 |
| Length of stay, days (median, range); n=261 | 5 (3–6) | |
| Post-operative complications | ||
| Surgical site infection (deep incisional or organ space) | 35 | 13.4 |
| Systemic sepsis | 0 | 0.0 |
| Post-operative VTE/PE | 9 | 3.4 |
| Pneumonia | 5 | 1.9 |
| Unplanned intubation | 0 | 0.0 |
| Myocardial infarction/cardiac event | 0 | 0.0 |
| UTI | 12 | 4.6 |
| Acute renal failure/insufficiency | 0 | 0.0 |
| Readmission | 25 | 9.6 |
| Reoperation | 4 | 1.5 |
| Any serious complication | 57 | 21.8 |
ASA, American Society of Anesthesiologists; BMI, body mass index; COPD, chronic obstructive pulmonary disease; EBL, estimated blood loss; UTI, urinary tract infection; VTE/PE, venous thromboembolic event/pulmonary embolus.